Kimberly J. Popovits
2017 - Genomic Health
In 2017, Kimberly J. Popovits earned a total compensation of $4.1M as President and Chief Executive Officer at Genomic Health, a 7% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $440,360 |
|---|---|
| Option Awards | $2,213,972 |
| Salary | $700,128 |
| Stock Awards | $762,845 |
| Total | $4,117,305 |
Popovits received $2.2M in option awards, accounting for 54% of the total pay in 2017.
Popovits also received $440.4K in non-equity incentive plan, $700.1K in salary and $762.8K in stock awards.
Rankings
In 2017, Kimberly J. Popovits' compensation ranked 2,476th out of 14,666 executives tracked by ExecPay. In other words, Popovits earned more than 83.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,476 out of 14,666 | 83rd |
Division Services | 468 out of 2,424 | 81st |
Major group Health Services | 33 out of 224 | 85th |
Industry group Medical And Dental Laboratories | 8 out of 64 | 88th |
Industry Medical Laboratories | 8 out of 64 | 88th |
Source: SEC filing on April 27, 2018.
Popovits' colleagues
We found four more compensation records of executives who worked with Kimberly J. Popovits at Genomic Health in 2017.